These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2525983)

  • 1. Etodolac, a new nonsteroidal anti-inflammatory drug: gastrointestinal microbleeding and endoscopic studies.
    Lanza FL; Arnold JD
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():5-15. PubMed ID: 2525983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal microbleeding associated with the use of etodolac, ibuprofen, indomethacin, and naproxen in normal males.
    Salom IL; Jacob G; Jallad N; Perdomo CA; Mullane JF; Weidler D
    J Clin Pharmacol; 1984; 24(5-6):240-6. PubMed ID: 6235249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the antiarthritic efficacy and safety of etodolac.
    Zvaifler N
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():43-53. PubMed ID: 2525982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal blood loss in arthritic patients receiving chronic dosing with etodolac and piroxicam.
    Jallad NS; Sanda M; Salom IL; Perdomo CS; Garg DC; Mullane JF; Weidler DJ
    Am J Med Sci; 1986 Nov; 292(5):272-6. PubMed ID: 2946224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etodolac, aspirin, and gastrointestinal microbleeding.
    Arnold JD; Mullane JF; Hayden DM; March L; Hart K; Perdomo CA; Fencik M; Berger AE
    Clin Pharmacol Ther; 1984 May; 35(5):716-21. PubMed ID: 6232035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent clinical experience with etodolac in the treatment of osteoarthritis of the knee.
    Platt PN
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():54-62. PubMed ID: 2525984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production.
    Laine L; Sloane R; Ferretti M; Cominelli F
    Gastrointest Endosc; 1995 Nov; 42(5):428-33. PubMed ID: 8566633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An endoscopic comparison of the effects of etodolac, indomethacin, ibuprofen, naproxen, and placebo on the gastrointestinal mucosa.
    Lanza F; Rack MF; Lynn M; Wolf J; Sanda M
    J Rheumatol; 1987 Apr; 14(2):338-41. PubMed ID: 2955117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of the efficacy of etodolac in arthritic disorders.
    Bacon PA
    Eur J Rheumatol Inflamm; 1990; 10(1):22-34. PubMed ID: 2146130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theoretical mechanism for the gastrointestinal safety of etodolac: selective sparing of cytoprotective prostaglandins.
    Dvornik D; Lee DK
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():16-24. PubMed ID: 2525980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy and comparative effects on gastric and duodenal mucosa of etodolac and naproxen in patients with rheumatoid arthritis using endoscopy.
    Taha AS; McLaughlin S; Sturrock RD; Russell RI
    Br J Rheumatol; 1989 Aug; 28(4):329-32. PubMed ID: 2525943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etodolac: efficacy in osteoarthritis and effects on chondrocyte function.
    Bacon PA
    Rheumatol Int; 1990; 10 Suppl():3-7. PubMed ID: 2150570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the knee.
    Watson MC; Brookes ST; Kirwan JR; Faulkner A
    Cochrane Database Syst Rev; 2000; (2):CD000142. PubMed ID: 10796306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects.
    Hunt RH; Bowen B; Mortensen ER; Simon TJ; James C; Cagliola A; Quan H; Bolognese JA
    Am J Med; 2000 Aug; 109(3):201-6. PubMed ID: 10974182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind gastroscopic evaluation of the effects of etodolac and naproxen on the gastrointestinal mucosa of rheumatic patients.
    Bianchi Porro G; Caruso I; Petrillo M; Montrone F; Ardizzone S
    J Intern Med; 1991 Jan; 229(1):5-8. PubMed ID: 1825323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etodolac: analgesic effects in musculoskeletal and postoperative pain.
    Pena M
    Rheumatol Int; 1990; 10 Suppl():9-16. PubMed ID: 2150571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of etodolac SR and naproxen on gastro-intestinal blood loss.
    Leese P
    Curr Med Res Opin; 1992; 13(1):13-20. PubMed ID: 1468240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International experience with etodolac therapy for rheumatoid arthritis: an interim report of comparative efficacy.
    Briancon D
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():63-72. PubMed ID: 2525985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability comparison of etodolac and piroxicam in the treatment of patients with osteoarthritis of the knee.
    Astorga Paulsen G; Baigun S; Galvao de Figueiredo J; Gomes de Freitas G
    Curr Med Res Opin; 1991; 12(6):401-12. PubMed ID: 1828415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding.
    Kaufman DW; Kelly JP; Sheehan JE; Laszlo A; Wiholm BE; Alfredsson L; Koff RS; Shapiro S
    Clin Pharmacol Ther; 1993 Apr; 53(4):485-94. PubMed ID: 8477566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.